Molybdenum in the premature infant.
The molybdenum (Mo) levels in the plasma and urine of 30 premature and 15 full-term infants have been compared with the Mo intakes and urine uric acid excretion (uric acid/creatinine ratio) produced by the Mo enzyme xanthine oxidase. The Mo intakes of full-term infants were 41 +/- 14 nmol/kg/day (mean +/- SEM). In the premature group breast milk supplied significantly less Mo (4.3 +/- 0.4 nmol/kg/day) than infant formulas (101 +/- 31 nmol/kg/day) or premature formula (255 +/- 13 nmol/kg/day). When fed breast milk, the preterm infants displayed similar or higher plasma and urine Mo and urine uric acid levels than formula-fed infants. For the whole preterm group a significant correlation was determined for urine Mo levels and Mo intakes as well as for plasma Mo and uric acid excretion. The bioavailability of breast milk Mo seems to be higher than formula Mo according to the Mo levels and to their statistical link with uric acid excretion which could be proposed as a functional index of Mo status. These parameters displayed similar values in breast milk-fed prematures and control full-term infants. The Mo needs of formula-fed premature newborns remain to be defined using complete balance trials.
Bougle
D
D
Département de Pédiatrie, CHU de Caen, France.
Foucault
D
D
Voirin
J
J
Bureau
F
F
Duhamel
J F
JF
D003404:Creatinine / Q000378:metabolism; D006801:Humans; D007225:Infant Food; D007231:Infant, Newborn; D007234:Infant, Premature / Q000097:blood / Q000378:metabolism* / Q000652:urine; D008895:Milk, Human; D008982:Molybdenum / Q000097:blood / Q000378:metabolism* / Q000652:urine; D014527:Uric Acid / Q000652:urine; D014969:Xanthine Oxidase / Q000378:metabolism
D014527:Uric Acid; D008982:Molybdenum; D003404:Creatinine; D014969:Xanthine Oxidase